This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Xeris Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Martin Cummins: Innovator in Diabetes Treatment
Introduction
Martin Cummins is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of diabetes treatment, particularly in addressing exercise-induced hypoglycemia. His innovative approach has the potential to improve the quality of life for individuals with diabetes.
Latest Patents
Cummins holds a patent for the "Treatment of exercise-induced hypoglycemia in type 1 and insulin using type 2 diabetes." This patent outlines methods for treating, ameliorating, or preventing exercise-induced or exercise-associated hypoglycemia. The invention involves the administration of glucagon or glucagon analog formulations to subjects prior to exercise, effectively managing their condition. He has 1 patent to his name.
Career Highlights
Martin Cummins is currently associated with Xeris Pharmaceuticals, Inc., where he continues to work on innovative solutions for diabetes management. His expertise and dedication to research have positioned him as a key player in the pharmaceutical industry.
Collaborations
Cummins collaborates with talented professionals such as Steven J Prestrelski and Brett Newswanger. Their combined efforts contribute to advancing research and development in diabetes treatment.
Conclusion
Martin Cummins exemplifies the spirit of innovation in the medical field, particularly in diabetes care. His work has the potential to make a lasting impact on the lives of many individuals living with diabetes.